High dose methotrexate therapy: Insecure rationale?

Barton A. Kamen; Naomi J. Winick

doi:10.1016/0006-2952(88)90032-9

High dose methotrexate therapy: Insecure rationale?

Research output: Contribution to journal › Article › peer-review

Original language	English (US)
Pages (from-to)	2713-2715
Number of pages	3
Journal	Biochemical Pharmacology
Volume	37
Issue number	14
DOIs	https://doi.org/10.1016/0006-2952(88)90032-9
State	Published - Jul 15 1988

ASJC Scopus subject areas

Biochemistry
Pharmacology

Access to Document

10.1016/0006-2952(88)90032-9

Cite this

@article{d6a5f3f07d734f6d914fd41f048ac624,

title = "High dose methotrexate therapy: Insecure rationale?",

author = "Kamen, {Barton A.} and Winick, {Naomi J.}",

note = "Funding Information: * The authors{\textquoteright} work was partially supported by ACS CH228 (B.A.K.) and ASCO (N.J.W.). t B.A.K. is a Burroughs Wellcome Clinical Pharmacology Scholar. $ Address correspondence to:.Barton A. Kamen, M.D., Ph.D., Department of Pediatrics, UTHSCD, 5323 Harry Hines Blvd., Dallas, TX 75235. Copyright: Copyright 2014 Elsevier B.V., All rights reserved.",

year = "1988",

month = jul,

day = "15",

doi = "10.1016/0006-2952(88)90032-9",

language = "English (US)",

volume = "37",

pages = "2713--2715",

journal = "Biochemical Pharmacology",

issn = "0006-2952",

publisher = "Elsevier Inc.",

number = "14",

}

TY - JOUR

T1 - High dose methotrexate therapy

T2 - Insecure rationale?

AU - Kamen, Barton A.

AU - Winick, Naomi J.

N1 - Funding Information: * The authors’ work was partially supported by ACS CH228 (B.A.K.) and ASCO (N.J.W.). t B.A.K. is a Burroughs Wellcome Clinical Pharmacology Scholar. $ Address correspondence to:.Barton A. Kamen, M.D., Ph.D., Department of Pediatrics, UTHSCD, 5323 Harry Hines Blvd., Dallas, TX 75235. Copyright: Copyright 2014 Elsevier B.V., All rights reserved.

PY - 1988/7/15

Y1 - 1988/7/15

UR - http://www.scopus.com/inward/record.url?scp=0023924833&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0023924833&partnerID=8YFLogxK

U2 - 10.1016/0006-2952(88)90032-9

DO - 10.1016/0006-2952(88)90032-9

M3 - Article

C2 - 3395351

AN - SCOPUS:0023924833

SN - 0006-2952

VL - 37

SP - 2713

EP - 2715

JO - Biochemical Pharmacology

JF - Biochemical Pharmacology

IS - 14

ER -

High dose methotrexate therapy: Insecure rationale?

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this